Inventor · disambiguated record
Junyou Ge
Also filed as: GE JUNYOU
0 granted patents·16 pending applications·0 citations·filing 2021–2024
Files withSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD11HITGEN INC2MERCK SHARP & DOHME LLC2CHENGDU KELUN PREC BIOTECHNOLOGY CO LTD1
Top patents by PatentIndex Score
16 records- 0162US2025000994A1Combination therapies for the treatment of non-small cell lung cancerMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 0262US2025295683A1Heterocyclic compound, preparation method therefor and application thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0361US2025195683A1Antibody-drug conjugate, pharmaceutical composition thereof and use therofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0460US2025161474A1Antibody-drug conjugates targeting egfr/c-met and preparation methods and uses thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 0559US2025049940A1Combined Use of Anti-TROP-2 Antibody-drug Conjugate and other Therapeutic AgentsSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0659US2024238434A1Use of medicament in treatment of tumor diseaseSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0759US2025000990A1Combination therapies for the treatment of cancerMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 0858US2025000997A1Method for improving quality of antibody-drug conjugate productSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0958US2025339548A1Method for treating cancer by using antibody-drug conjugate and useSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1055US2024252665A1Chemical coupling linker and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1154US2025223352A2Anti-nectin-4 antibody, conjugate including the same, and application thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 1254US2025333409A1Compound and use thereof in preparation of BCL-XL inhibitorHITGEN INC·Filed 2023·Application pending·0 cites
- 1353US2023312556A1Arylamide compound, pharmaceutical composition comprising same, and preparation method therefor and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 1453US2024269312A1Antibody drug conjugate, and preparation method therefor and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1553US2025136593A1Degradation agent and use thereofHITGEN INC·Filed 2022·Application pending·0 cites
- 1649US2025269026A1Chimeric antigen receptor which specifically binds to msln, and application thereofCHENGDU KELUN PREC BIOTECHNOLOGY CO LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Junyou Ge files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →